Ludwig Institute for Cancer Research

Anti-CD25 [PC61 5.3]

Invented at Ludwig Institute for Cancer Research

FACS IHC IP

Antigen/Gene or Protein Targets: CD25

0 reviews 1 reference 1 supplier

Anti-MAGE-1 [MA454]

Invented at Ludwig Institute for Cancer Research

IHC WB

Antigen/Gene or Protein Targets: MAGE-1

0 reviews 1 reference 1 supplier

p110beta PI3K-D931A (129)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 2 suppliers

p110beta PI3K-D931A (B6)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 2 suppliers

p110beta PI3K-D931A(BALBc)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 1 supplier

p110beta PI3K-D931A-LacZ

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research The University of Edinburgh

Antigen/Gene or Protein Targets: PIK3CB

0 reviews Add a reference 1 supplier

p110beta PI3K-DEL21/22(129)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research The University of Edinburgh

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 2 suppliers

p110beta PI3K-DEL21/22 (B6)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research The University of Edinburgh

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 1 supplier

p110beta PI3K-floxed

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research The University of Edinburgh

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 2 suppliers

Pik3ca-H1047R conditional – Flp inducible

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research

Antigen/Gene or Protein Targets: PIK3CA

0 reviews 1 reference 2 suppliers

Anti-CD25 [PC61 5.3]

Invented at Ludwig Institute for Cancer Research

FACS IHC IP

Antigen/Gene or Protein Targets: CD25

0 reviews 1 reference 1 supplier

Anti-MAGE-1 [MA454]

Invented at Ludwig Institute for Cancer Research

IHC WB

Antigen/Gene or Protein Targets: MAGE-1

0 reviews 1 reference 1 supplier

p110beta PI3K-D931A (129)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 2 suppliers

p110beta PI3K-D931A (B6)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 2 suppliers

p110beta PI3K-D931A(BALBc)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 1 supplier

p110beta PI3K-D931A-LacZ

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research The University of Edinburgh

Antigen/Gene or Protein Targets: PIK3CB

0 reviews Add a reference 1 supplier

p110beta PI3K-DEL21/22(129)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research The University of Edinburgh

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 2 suppliers

p110beta PI3K-DEL21/22 (B6)

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research The University of Edinburgh

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 1 supplier

p110beta PI3K-floxed

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research The University of Edinburgh

Antigen/Gene or Protein Targets: PIK3CB

0 reviews 2 references 2 suppliers

Pik3ca-H1047R conditional – Flp inducible

Invented by Bart Vanhaesebroeck at Ludwig Institute for Cancer Research

Antigen/Gene or Protein Targets: PIK3CA

0 reviews 1 reference 2 suppliers

Nadette Bulgin

from Ludwig Institute for Cancer Research

0  reagents 0  reviews

Luc Pilotte

from Ludwig Institute for Cancer Research

0  reagents 0  reviews